Skip to main content
. 2013 Nov 13;77(6):947–957. doi: 10.1111/bcp.12282

Table 2.

Aims of research and appropriate biomarkers

Aim: Suitable marker
Monitoring general kidney function (GFR) CysC
Differentiate between glomerular and tubular damage KIM-1, clusterin, αGST
Monitor toxicity with suspected glomerular localization B2M
Monitor toxicity with suspected non-glomerular localization CysC, NGAL,
Detect early kidney injury with suspected proximal tubular localization αGST, KIM-1
Monitor reversibility/regeneration with suspected proximal tubular localization KIM-1
Monitor toxicity with suspected distal tubular localization Clusterin
Monitor reversibility/regeneration with suspected distal tubular localization Clusterin
Elucidate pathophysiological mechanism with known proximal tubular injury site NAG
High risk of acute tubular necrosis (Phase II/III trials) IL18